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Background: Tibia shaft fractures (TSF) are common for men and women and cause substantial morbidity,
healthcare use, and costs. The impact of nonunions on healthcare use and costs is poorly described. Our goal was
to investigate patient characteristics and healthcare use and costs associated with TSF in patients with and without
nonunion.
Methods: We retrospectively analyzed medical claims in large U.S. managed care claims databases (Thomson
Reuters MarketScanW, 16 million lives). We studied patients≥ 18 years old with a TSF diagnosis (ICD-9 codes: 823.20,
823.22, 823.30, 823.32) in 2006 with continuous pharmaceutical and medical benefit enrollment 1 year prior and
2 years post-fracture. Nonunion was defined by ICD-9 code 733.82 (after the TSF date).
Results: Among the 853 patients with TSF, 99 (12%) had nonunion. Patients with nonunion had more
comorbidities (30 vs. 21, pre-fracture) and were more likely to have their TSF open (87% vs. 70%) than those
without nonunion. Patients with nonunion were more likely to have additional fractures during the 2-year follow-up
(of lower limb [88.9% vs. 69.5%, P < 0.001], spine or trunk [16.2% vs. 7.2%, P = 0.002], and skull [5.1% vs. 1.3%,
P = 0.008]) than those without nonunion. Nonunion patients were more likely to use various types of surgical care,
inpatient care (tibia and non-tibia related: 65% vs. 40%, P < 0.001) and outpatient physical therapy (tibia-related: 60%
vs. 42%, P < 0.001) than those without nonunion. All categories of care (except emergency room costs) were more
expensive in nonunion patients than in those without nonunion: median total care cost $25,556 vs. $11,686,
P < 0.001. Nonunion patients were much more likely to be prescribed pain medications (99% vs. 92%, P = 0.009),
especially strong opioids (90% vs. 76.4%, P = 0.002) and had longer length of opioid therapy (5.4 months vs. 2.8
months, P < 0.001) than patients without nonunion. Tibia fracture patterns in men differed from those in women.
Conclusions: Nonunions in TSF’s are associated with substantial healthcare resource use, common use of strong
opioids, and high per-patient costs. Open fractures are associated with higher likelihood of nonunion than closed
ones. Effective screening of nonunion risk may decrease this morbidity and subsequent healthcare resource use
and costs.
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Tibia shaft fractures are common but unanticipated
trauma in adults resulting in painful and prolonged re-
covery, often associated with complications. The U.S.
National Center for Health Statistics reported annual in-
cidence of 492,000 fractures of tibia, fibula, and ankle
[1]. Tibia and fibula fractures annually result in 77,000
hospitalizations accounting for 569,000 hospital days
and 825,000 physician office visits [2]. The U.S. Agency
for Healthcare Research and Quality (AHRQ) reported
151,966 hospital discharges for which tibia/fibula* Correspondence: Antonova.Jenya@gmail.com
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reproduction in any medium, provided the orfracture diagnosis was a reason for a principal procedure
in 2007 (Healthcare Cost and Use Project, AHRQ) [3]. A
high proportion of Medicare patients – adults aged 65
or older – with tibia fractures undergo an acute inpa-
tient stay (70%), post-acute inpatient stay (50%), and
home health care (38%) as well as outpatient visits and
physical and occupational therapy [4]; such estimates are
missing for young and middle-age adults who also fre-
quently get tibia fractures [5,6]. Tibia fractures are trea-
ted medically, and healthcare use depends on treatment
options, which, in turn, vary by injury type and severity
and the presence of complications [5,7].
Fracture nonunion (sometimes referred to as “delayed
union”) is a common complication of a tibia fracture; itral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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timely fashion [5,8]. Nonunions put additional burden
on the patient because they prolong the disability and
are associated with substantial pain [9,10]. There is no
standard definition of nonunion, and some authors have
defined tibia nonunion as a fracture that has not united
without additional surgical or nonsurgical intervention
within 6–9 months [8], whereas others waited for six-
month to perform surgeries to correct nonunions [11].
A common approach to delayed unions is expectant
management, accompanied by non-invasive therapies
such as low-intensity pulsed ultrasound [12-14], or vi-
bration [12]. When healing fails within a clinically rea-
sonable time period (6–9 months), a second surgical
intervention, aiming to stabilize the fracture, is inevitable
[8,11]. Additional therapies used during the surgery,
such as bone morphogenetic proteins (BMP’s), may fur-
ther help bone healing, but they are costly.
Nonunions naturally require more healthcare services
than fractures without non-unions because of the repea-
ted surgical intervention and the extended patient pain
and disability. Understanding of patient characteristics,
healthcare use, and costs associated with tibia fracture
nonunion is critical to understanding the clinical and eco-
nomic burden.
Although previous studies investigated nonunion-re-
lated healthcare use and costs [15-18], they had a num-
ber of limitations: small sample size (n < =27) [15-18],
no comparison to patients without nonunion [15-18],
outdated estimates [15,18], single healthcare setting [15],
and focus on limited therapies: pulsed low-intensity ul-
trasound [18], autologous-iliac-crest-bone-graft, or bone
morphogenetic protein-7 (BMP-7) [16,17]. These short-
comings limit the reliability of the estimates, external
validity (the ability to generalize to other patient popula-
tions and healthcare settings), and the ability compare
with costs of fractures with nonunion to those without
nonunion. To address these shortcomings, we conducted
an analysis of large U.S. medical claims databases that
reflects multiple healthcare settings and therapies. The
aim of our study was to describe patient characteristics,
healthcare resource use, and costs associated with tibia
shaft fractures overall and by nonunion status.
Methods
Data
We used data from the Thomson Reuters MarketscanW
Research Databases. These retrospective claims databases
are fully compliant with the Health Insurance Portabili-
ty and Accountability Act (HIPAA). The data capture
person-specific healthcare use, expenditures, and en-
rollment in inpatient, outpatient, prescription-drug, and
carve-out servicesa from a selection of large employers,
health plans, and government and public organizations.The databases link paid claims and healthcare encounter
data to detailed patient information (for multiple sites and
types of providers) over time. The databases include pri-
vate sector health data from approximately 100 payers and
more than 500 million claim records throughout the Uni-
ted States. The examined data spanned the years 2005
through 2008 and reflected approximately 16 million pa-
tient lives. This study did not enroll human subjects.
Patient sample
This study included adult patients diagnosed with a tibia
shaft fracture (sometimes accompanied with a fibula frac-
ture), which included ICD-9-CM diagnostic codes 823.20,
823.22, 823.30, and 823.32. The fractures occurred during
the calendar year 2006 (the index period). Patients were
required to have continuous insurance coverage in the year
prior to the index period (2005) and during the two years
following the index period (2007–2008). Please see Online
Additional file 1 for more details. We excluded patients
who were diagnosed with a tibia fracture in the calendar
year prior to the index period and patients who were
younger than 18 years at the time of their tibia shaft frac-
ture. Nonunion was defined by ICD-9 code 733.82
recorded after the initial tibia fracture date.
Measures
We extracted the following data for each patient in the
sample: age, sex, comorbidities, additional fractures, non-
union status (yes or no), open vs. closed status of the tibia
fracture, use of pain medications, healthcare resource use,
and medical costs. Healthcare use and costs included all in-
patient, outpatient, and pharmacy services billed for during
the 24 months after the tibia fracture. Costs were divided
into tibia related (whenever tibia fracture diagnosis code
was assigned to the medical claim) and non-tibia related
(whenever tibia fracture diagnosis code was not assigned to
the medical claim). Opioids were classified as “weak” (tra-
madol and hydrochloride) and “strong” (all others). We
assigned “open” fracture status to the cases with an open
fracture record in the tibia shaft related claims. Cases with
fractures (other than the index fracture) recorded in claims
in the 2-year follow-up period received the “additional frac-
ture” status.
Analyses
We described demographic characteristics (age and sex)
for all tibia fracture patients (total and by nonunion sta-
tus). We compared healthcare resource use and medical
costs of tibia shaft fracture in patients with and without
nonunion. The Charlson comorbidity index (CCI) [18]
was used to estimate patient general health status. Costs
and health care resources were annualized and converted
into 2006 U.S. dollars. Costs were analyzed as tibia-
related, non-tibia related, and total.
Figure 1 Distribution of tibia fractures in age categories by sex.
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In statistical comparisons, we used Chi-square tests to
examine differences in patient counts. We used a non-
parametric technique - Wilcoxon test - to compare con-
tinuous variables (to minimize the influence of cost
outliers). P values < 0.05 were considered to be statis-
tically significant. We conducted analyses using SAS,
version 9.3 (Cary, NC).
Internal Review Board (IRB) approval was not required
for this retrospective database study because the dataTable 1 Patient characteristics by the nonunion status
Characteristic All N = 853 With nonunion N
N % N
Sex:
Male 378 44.3% 47
Female 475 55.7% 52











Lower Limb 612 71.70% 88 8
Upper Limb 90 10.60% 12 1
Spine and Trunk 70 8.20% 16 1
Skull 15 1.80% 5
Open fracture status
Open 132 15.5% 30
Closed 721 84.5% 69
Notes: † P-value is based on the T-test, ‡ P-value is based on the Wilcoxon test; ξ -were de-identified and followed the HIPAA guidelines
prior to our analyses.
Results
A total of 853 tibia fracture patients were selected for
the study based on the inclusion and exclusion criteria
above.
Tibia fracture patient characteristics: age and sex
Average patient age at the time of fracture varied by sex.
The male tibia fracture patients were most likely to be
between their forties and fifties (Figure 1) with the mean
age 50 years old (y.o.) (median age = 51 y.o.). In contrast,
the female tibia fracture patients were most likely to
be 65 y.o. or older, and the mean age at the time of
the fracture in women was 56 y.o. (median age = 57 y.o.).
Age difference between sexes was statistically significant
(p < 0.001).
Tibia fracture patient characteristics by nonunion status
Out of 853 patients with a tibia shaft fracture, 99 (12%)
patients had a nonunion diagnosis associated with their
tibia fracture treatment. Patients with nonunion had
characteristics similar to those without nonunion: there= 99 Without nonunion N = 754 P values
% N %










8.90% 524 69.50% < 0.001†
2.10% 78 10.30% 0.59†
6.20% 54 7.20% 0.0022†
5.10% 10 1.30% 0.008†
30.3% 102 13.5% < 0.001ξ
69.7% 652 86.5%
P-value is based on the Chi-Square test; SD – standard deviation.
Table 2 Prescription medications use in patients with a tibia shaft fracture by nonunion status
Prescription Medications All tibia fractures (N = 853) With Nonunion (N = 99) Without Nonunion (N = 754) P values
Any Pain Medication
Patients on therapy, n (%) 795 (93.2%) 98 (99.0%) 697 (92.4%) 0.009†
• Average therapy duration, months (SD) N/A N/A N/A X
Strong Opioids
• Patients on therapy, n (%) 665 (78.0%) 89 (89.9%) 576 (76.4%) 0.002†
• Average therapy duration, months (SD) 3.2 (5.5) 5.4 (6.8) 2.8 (5.2) < 0.001‡
Prescription NSAIDs
• Patients on therapy, n (%) 301 (35.3%) 47 (47.5%) 254 (33.7%) 0.007†
• Average therapy duration, months (SD) 3.6 (4.9) 4.3 (6.0) 3.5 (4.7) 0.67‡
Weak Opiods
• Patients on therapy, n (%) 247 (29.0%) 34 (34.3%) 213 (28.2%) 0.21†
• Average therapy duration, months (SD) 2 (3.5) 2.2 (3.5) 2.0 (3.5) 0.13‡
Benzodiazepines
• Patients on therapy, n (%) 235 (27.5%) 36 (36.4%) 199 (26.4%) 0.037†
• Average therapy duration, months (SD) 7.2 (7.6) 7.4 (8.5) 7.1 (7.4) 0.68‡
Antidepressants: SSRI
• Patients on therapy, n (%) 220 (25.8%) 30 (30.3%) 190 (25.2%) 0.28†
• Average therapy duration, months (SD) 11.6 (7.2) 8.1 (6.6) 12.1 (7.1) 0.003‡
Corticosteroids
• Patients on therapy, n (%) 201 (23.6%) 27 (27.3%) 174 (23.1%) 0.36†
• Average therapy duration, months (SD) 1.9 (4.1) 2.3 (4.4) 1.9 (4.1) 0.21‡
Non-Benzodiazepines Sedative/Hypnotics
• Patients on therapy, n (%) 197 (23.1%) 29 (29.3%) 168 (22.3%) 0.12†
• Average therapy duration, months (SD) 4.4 (5.7) 3.8 (3.9) 4.5 (6)
Muscle Relaxants
• Patients on therapy, n (%) 174 (20.4%) 25 (25.3%) 149 (19.8%) 0.2†
• Average therapy duration, months (SD) 3.9 (6) 5.0 (6.5) 3.7 (6.0) 0.061‡
Inject Corticosteroid
• Patients on therapy, n (%) 168 (19.7%) 28 (28.3%) 140 (18.6%) 0.022†
• Average therapy duration, months (SD) 0.1 (0.1) 0.1 (0.1) 0.1 (0.1) 0.75‡
Anticonvulsant/Antiepileptic
• Patients on therapy, n (%) 128 (15.0%) 23 (23.2%) 105 (13.9%) 0.015†
• Average therapy duration, months (SD) 8.3 (7.1) 9.1 (7.6) 8.1 (7.0) 0.59‡
Antidepressants: Other
• Patients on therapy, n (%) 92 (10.8%) 13 (13.1%) 79 (10.5%) 0.42†
• Average therapy duration, months (SD) 9.7 (8.0) 8.4 (7.7) 10.0 (8.1) 0.76‡
Antidepressants: SNRI
• Patients on therapy, n (%) 77 (9.0%) 19 (19.2%) 58 (7.7%) < 0.001†
• Average therapy duration, months (SD) 10 (7.3) 12.0 (7.8) 9.3 (7.0) 0.22‡
Antidepressants: TCAs
• Patients on therapy, n (%) 71 (8.3%) 11 (11.1%) 60 (8.0%) 0.29†
• Average therapy duration, months (SD) 8.5 (7.7) 8.4 (9.1) 8.5 (7.5) 0.6‡
COX-2 Inhibitors
• Patients on therapy, n (%) 62 (7.3%) 10 (10.1%) 52 (6.9%) 0.25†
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Table 2 Prescription medications use in patients with a tibia shaft fracture by nonunion status (Continued)
• Average therapy duration, months (SD) 7.2 (7.2) 6.7 (8.0) 7.3 (7.2) 0.6‡
Analgesics/Antipyretics, NEC
• Patients on therapy, n (%) 13 (1.5%) 1 (1.0%) 12 (1.6%) 1.0†
• Average therapy duration, months (SD) 1.3 (2.7) 2 (MISS) 1.3 (2.8) 0.28‡
Notes: † P-value is based on the T-test, ‡ P-value is based on the Wilcoxon test; SD – standard deviation; NSAID - non-steroidal anti-inflammatory drugs;
SSRI - selective serotonin reuptake inhibitors; SNRI - Serotonin–norepinephrine reuptake inhibitors; TCA - Tricyclic antidepressants; NEC – not elsewhere classified.
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gion of residence, type of insurance coverage, or CCI
(Table 1).
Patients with open tibia shaft fractures were much
more likely to develop a nonunion than those with clo-
sed fractures. Ten percent (69/721) of patients with a
closed fracture developed a nonunion compared with
23% (30/132) of open fractures patients (p < 0.001, Table 1).
Also, patients with nonunion were more likely to have
additional fractures during the 2-year follow-up (of lower
limb [88.9% vs. 69.5%, P < 0.001], spine or trunk [16.2% vs.
7.2%, P = 0.002], and skull [5.1% vs. 1.3%, P = 0.008]) than
those without nonunion (Table 1).
Healthcare resource use
Tibia fracture patients consumed a substantial amount
of prescription medications (Table 2). Overall, more
than nine out of ten (93.2%) tibia shaft fracture pa-
tients used prescription medications during the 2-year
follow-up period. The most common prescription me-
dications among all tibia shaft patients were strong opi-
oids (78.0%) and non-steroidal anti-inflammatory drugs
(NSAID, 35.3%).
A higher proportion of nonunion patients used medi-
cations than those without nonunion (99.0% vs. 92.4%,
P = 0.009). This disparity was driven by the followingFigure 2 Post-fracture surgical procedures by nonunion status.medications: strong opioids (89.9% vs. 76.4%, P = 0.002),
prescription NSAID’s (47.5% vs. 33.7%, P = 0.007), benzo-
diazepines (36.4% vs. 26.4%, P = 0.037), injectable cortico-
steroid (28.3% vs. 18.6%, P = 0.022). Nonunion patients
not only were more likely to used strong opioids than
their counterparts without nonunion, but also used them
for almost twice as long as those without nonunion (5.4
vs. 2.8 months, P < 0.001). Interestingly, although a higher
proportion of nonunion patients used selective serotonin
reuptake inhibitors (SSRI’s) than those without nonunion,
the duration of SSRI therapy was shorter in the nonunion
patients than in those without nonunion (8.1 vs. 12.1
months, P = 0.003).
Nonunion patients received significantly more surgical
procedures than their counterparts without nonunion
(Figure 2). Almost a third (29%) of nonunion patients
required repair, one in nine (11%) required osteotomy,
and 4% required osteoplasty, whereas none of those
without nonunion required these procedures. Almost
five-fold difference existed between the rate of external
fixation (25% vs. 4%, P < 0.0001) and percutaneous skel-
etal fixation (5% vs. 1%, P = 0.0045) in those with and
without nonunion. Also, nonunion patients were more
likely to receive an open treatment with internal fixation
(25% vs. 12%, P = 0.0002) or plates and screws (13% vs.
7%, P = 0.044), a closed treatment without manipulation
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vs. 26%, P = 0.0005) than patients without nonunion. No
statistically significant difference existed between patients
with and without nonunion in two procedures: closed
treatment with manipulation and open treatment without
manipulation.
Other healthcare resources followed a similar pattern
(Table 3). Nonunion patients were more likely to be
hospitalized for reasons related to the tibia fracture
(64.6% vs. 40.3%, P < 0.001) and other reasons (62.6%
vs. 31.6%, P < 0.001) and to use tibia-related physical
therapy (59.6% vs. 42.4%, P = 0.001) than their coun-
terparts without nonunion. Other services were com-
parable between the two groups.
Medical costs
Medical costs of nonunion tibia shaft fracture patients
were higher than of their counterparts without non-
union. This was true for services directly related to tibia
fractures and other services, even if some of them had a
comparable rate of use between the groups (Table 4 lists
median and mean treatment costs with standard devia-
tions). This was true for almost all types of healthcare
services: directly related to tibia fracture and other ser-
vices. This resulted in median total care cost for non-
union patients almost doubling that of patients without
a nonunion ($25,555.97 vs. $11,686.24, P < 0.001). Me-
dian costs of inpatient services not related to tibia frac-
tures were almost 20 times higher in nonunion patients
than in those without nonunion ($7,214.43 vs. $368.81,
P < 0.001). Although both groups used outpatientTable 3 Healthcare resource utilization in tibia shaft fracture
All tibia fractures N = 853: N (%) With nonunio
Tibia Fracture R
Inpatient 368 (43.1%) 64 (6
Outpatient 751 (88.0%) 86 (8
Physical Therapy 379 (44.4%) 59 (5
Emergency Room 67 (7.90%) 6 (6
Total 853 (100.00%) 99 (10
Non-Tibia Fracture
Inpatient 300 (35.20%) 62 (6
Outpatient 853 (100.00%) 99 (10
Emergency Room 287 (33.60%) 41 (4
Total 853 (100.00%) 99 (10
Total V
Inpatient 529 (62.00%) 85 (8
Outpatient 853 (100.00%) 99 (10
Emergency Room 324 (38.00%) 44 (4
Overall Total 853 (100.00%) 99 (10
Notes: † P-value is based on the T-test.services with similar likelihood (Table 3), the median
costs of these services were higher in the nonunion
patients than in those without nonunion for both tibia
related ($674.05 vs. $150.1, P < 0.001) and non-tibia
related ones ($9,952.65 vs. $3,850.53, P < 0.001).Discussion
Tibia shaft fractures present a substantial burden on
patients and the healthcare system. These fractures are
common and cause physical limitations and pain to the
patients. Nonunions further worsen the burden of tibia
shaft fractures and lead to additional healthcare inter-
ventions [9,18]. Although nonunion can occur in any
fracture site, tibia shaft is the most common among the
long bones [19-21]. The extent of the healthcare burden
and costs associated with tibia shaft fractures needs to be
well understood to enhance the framework of decision
making regarding treatment patterns and health insurance
coverage, and to better evaluate the outcomes of non-
union fracture prevention and treatment. This study
addressed an important gap in the literature: the lack of
recent and broadly representative data on healthcare use
and cost of tibia fracture treatment depending on the non-
union status.
Women with tibia fractures were found to be older
than men, and this difference was statistically significant.
Men tend to break their tibias in sport activities (e.g.
soccer and skiing) or motor vehicle accidents [6]. In
women, low bone mass and osteoporosis (common for
old ages) are contributing factors to tibia fractures [22].patients by nonunion status
n N = 99: N (%) Without nonunion N = 754: N (%) P Values †
elated Visits
4.60%) 304 (40.30%) < 0.001
6.90%) 665 (88.20%) 0.7
9.60%) 320 (42.40%) 0.0012
.10%) 61 (8.10%) 0.48
0.00%) 754 (100.00%) NA
Related Visits
2.60%) 238 (31.60%) < 0.001
0.00%) 754 (100.00%) NA
1.40%) 246 (32.60%) 0.082
0.00%) 754 (100.00%) NA
isits
5.90%) 444 (58.90%) < 0.001
0.00%) 75 (400.00%) NA
4.40%) 280 (7.10%) 0.16
0.00%) 754 (100.00%)
Table 4 Medical costs associated with tibia shaft fracture patients by nonunion status
Medical and Pharmacy Costs All Tibia Fractures N = 853 Nonunion N = 99: Without Nonunion N = 754: P values†
Tibia Fracture Related Costs
Inpatient
< 0.001
• Median $0.00 $1,115.92 $0.00
• Mean $3,378.69 $7,263.96 $2,868.56
• SD $10,652.67 $16,129.49 $9,607.02
Outpatient
< 0.001
• Median $178.06 $674.05 $150.10
• Mean $584.24 $1,300.95 $490.14
• SD $1,505.94 $2,414.03 $1,315.75
Emergency Room
0.52
• Median $0.00 $0.00 $0.00
• Mean $32.34 $23.03 $33.56
• SD $261.46 $134.00 $273.86
Total
< 0.001
• Median $663.50 $2,316.07 $531.97
• Mean $3,995.27 $8,587.94 $3,392.25
• SD $10,811.50 $16,306.36 $9,721.82
Non-Tibia Fracture Related Costs
Inpatient
< 0.001
• Median $611.98 $7,214.43 $368.81
• Mean $8,735.48 $25,487.19 $6,535.98
• SD $23,600.99 $51,161.42 $15,743.06
Outpatient
< 0.001
• Median $4,317.24 $9,952.65 $3,850.53
• Mean $8,836.56 $15,736.12 $7,930.64
• SD $13,962.48 $17,527.29 $13,172.68
Emergency Room
0.049
• Median $0.00 $0.00 $0.00
• Mean $260.65 $292.16 $256.52
• SD $1,314.07 $715.34 $1,373.70
Total
< 0.001
• Median $7,114.27 $18,630.94 $6,086.31
• Mean $17,832.68 $41,515.47 $14,723.14




• Median $3,899.27 $9,697.55 $2,972.25
• Mean $12,114.17 $32,751.14 $9,404.54
• SD $26,874.18 $56,070.29 $18,565.20
Outpatient
< 0.001
• Median $4,869.33 $10,735.37 $4,419.38
• Mean $9,420.80 $17,037.08 $8,420.78
• SD $14,151.75 $18,219.82 $13,220.11
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Table 4 Medical costs associated with tibia shaft fracture patients by nonunion status (Continued)
Emergency Room
0.11
• Median $0.00 $0.00 $0.00
• Mean $292.99 $315.19 $290.07
• SD $1,340.86 $732.55 $1,401.56
Pain Medications
< 0.001
• Median $110.12 $380.98 $92.75
• Mean $655.29 $1,034.90 $605.44
• SD $2,144.27 $1,633.62 $2,198.56
Other Medications
0.61
• Median $1,117.06 $1,117.47 $1,109.45
• Mean $2,274.94 $2,368.05 $2,262.71
• SD $3,539.38 $3,375.77 $3,562.27
Overall Total
< 0.001
• Median $13,364.57 $25,555.97 $11,686.24
• Mean $24,758.18 $53,506.36 $20,983.55
• SD $35,245.19 $65,259.77 $26,987.93
Notes: † P-value is based on the Wilcoxon test. SD – standard deviation.
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in tibia shaft fracture treatment, especially when a non-
union is present [21]. Patients reported lower limb frac-
tures as the most painful ones among fractures and
injuries [23], which naturally drives the use of analgesics.
Consistent with previous literature, we found opioids
and NSAIDs to be commonly used for pain treatments
among patients with bone shaft trauma [24-26]. Notably,
other studies have shown a significant association be-
tween the use of NSAIDs [24,26] or opioids [26] with
nonunion of long bone shaft fractures. We also found
that patients with nonunion were more likely to experi-
ence additional fractures in the study period than those
without nonunion, which could have increased their likeli-
hood of receiving NSAIDs, opioids, or both. Although our
study design precluded us from any inferences of causality,
our results suggest that pain medication (especially opioid)
use remains high in tibia shaft fracture patients with non-
union and may be a marker for nonunions.
Strong opioid use itself is a difficult issue in pain ma-
nagement of tibia fractures. Opioids are controlled sub-
stances that are associated with side effects, physical
tolerance, withdrawal, and addiction [27]. We found sub-
stantially higher use of strong opioids in tibia fracture
patients with nonunion than in those without nonunion.
Because extended use of strong opioids may result in pa-
tient addiction, and drug misuse and diversion [28], previ-
ous research suggested cautious use of strong opioids [28].
Thus, prevention or prompt treatment of nonunions may
not only help reduce pharmacy and medical costs, but
may also lead to better control over opioid use.Healthcare use and costs were higher in the nonunion
group than in those without nonunion. Although the
nonunion patients represented only 12% of the tibia shaft
fracture patient population, their total costs were more
than twice as much as those without a nonunion. This
happened because nonunion patients were more likely to
use all types of healthcare services than those without
nonunion, and their per-patient cost of care was higher
than in those without nonunion. We also found that non-
union patients underwent more surgical procedures post-
fracture than their counterparts without nonunion. These
findings are consistent with earlier reports suggesting that
nonunion patients were more likely to be hospitalized
[16,17] and operated on [15] than patients without non-
union. We found that both tibia and non-tibia related
costs were higher in patients with a nonunion. This may
indicate that tibia nonunion has an overall negative impact
on other aspects of people’s health and causes further
non-tibia-related healthcare resource use. Overall, our
findings provide an update on medical costs of tibia shaft
nonunion to the existing literature [15,18] and data on
healthcare use in a broader patient population group than
previously reported (BMP-7 treatment patients) [16,17].
While the healthcare system is under increasing finan-
cial burden, many healthcare institutions implement cost
control strategies. Screening tibia shaft fracture patients
for nonunion risks and addressing nonunions in a timely
manner, may not only free up scarce healthcare resour-
ces and save healthcare dollars, but also improve patient
outcomes [12]. The literature suggests that open frac-
tures are more likely to result in a nonunion than closed
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http://www.biomedcentral.com/1471-2474/14/42ones [21,25,29,30]. Consistently, our study found that
tibia shaft fracture nonunions were more likely to occur
in those whose tibia fracture was open than in those
with closed tibia fractures. Open status of a tibia shaft
fracture may serve as a pre-cursor of nonunion.
The findings of this research should be interpreted in
the context of the limitations of the study design. First,
our study focused exclusively on patients with medical
and prescription benefit coverage. Therefore, it may not
be appropriate to draw inferences about broader popula-
tions (especially those without health care insurance)
based on the findings presented here. Second, this study
was descriptive in nature and did not investigate the
effect of fracture-related characteristics (e.g., displaced,
compound, or comminuted) or patient-related character-
istics (e.g., smoking [31-33]) on the risk of nonunion.
Smoking status, among other patient-related characteris-
tics, was not available in the studied dataset. Third, the
limitations of the databases precluded us from detailing
specific within-hospital resource use (e.g., surgical the-
atre vs. other resources) or estimate whether all tibia
fracture healed by the end of the study period.
Finally, we were unable to assess the burden of tibia
shaft fracture nonunion beyond medical costs: e.g., on
patients’ health-related quality of life or indirect costs to
the society. Previous U.S. and the U.K. studies have
found that the indirect costs of tibia fracture manage-
ment are at least twice that of the direct healthcare costs
[18,34,35]. Given the substantial burden of tibia shaft
fractures not only on patients, but also on their family
members and friends, there is a need to estimate indirect
(e.g., productivity) costs of tibia shaft fractures and their
nonunion.Conclusions
In conclusion, this retrospective descriptive analysis of
patients with tibia shaft fractures revealed important dif-
ferences between those with nonunion and their counter-
parts without a nonunion. Although we identified higher
patient comorbidities, resource use, and costs associated
with nonunions, many unanswered questions, especially
as related to the indirect burden on society and risk fac-
tors for nonunion, still remain. Future research (prefer-
ably, through a prospective cohort or a placebo-controlled
study) should investigate functional and productivity out-
comes of tibia shaft fractures, risk factors for their non-
union, and the correlation between risk factors, such as
opioid use, and additional fractures.Endnotes
aCarve-out services are medical services that are se-
parated from a contract and paid under a different
arrangement.Additional file
Additional file 1: Index Tibia Fracture Diagnosis.
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